C12P 19/485
Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons
Official title: {Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52 (see also C12P19/54)}
C12P19/485 (Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons) appears on 17 US grants and 6 published applications in this corpus.
Search patents in C12P- Granted patents
- 17
- Published applications
- 6
- Assignees
- 13
- Inventors
- 59
- Latest grant
- 2 Jul 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Kanamycin compound, kanamycin-producing Streptomyces species bacterium, and method of producing kanamycin2 Jul 2019US 10,337,044 B2Intron Biotechnology, Inc.
- Aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof18 Oct 2016US 9,469,863 B2Meiji Seika Kaisha, Ltd.
- Kanamycin compound, kanamycin-producing Streptomyces species bacterium, and method of producing kanamycin15 Sep 2015US 9,133,492 B2Intron Biotechnology, Inc.
- Process for the improvement of antibiotic production by in vivo genetic recombination8 Mar 1988US 4,729,951 ABiogal Gyogyszergyar
- Novel compounds of the gentamicin class25 Oct 1983US 4,412,068 ASterling Drug Inc.
- Recombinant Escherichia Coli for Expressing Synthesis Pathway of Asiaticoside and Application Thereof12 Sep 2024US 2024/0301461 A1Jiangnan University
- Novel aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof22 Dec 2016US 2016/0367585 A1Meiji Seika Kaisha, Ltd.
- Means and methods for increasing antibiotic activity17 Nov 2016US 2016/0331708 A1
- Kanamycin compound, kanamycin-producing streptomyces species bacterium, and method of producing kanamycin11 Feb 2016US 2016/0040206 A1Intron Biotechnology, Inc.
- New kanamycin compound, kanamycin-producing streptomyces species bacterium, and method of producing kanamycin18 Apr 2013US 2013/0096078 A1Ewha University-Industry Collaboration Foundation
Most cited
By later US patents
- Process for the improvement of antibiotic production by in vivo genetic recombination25US 4,729,951 ABiogal Gyogyszergyar · 1988
- 2-Hydroxy gentamicin compounds6US 4,387,219 ASterling Drug Inc. · 1983
- Process for production of aminoglycoside antibiotics5US 4,279,997 AYamanouchi Pharmaceutical Co., Ltd. · 1981
- Fermentative process for preparing antibiotics of the gentamicin class3US 4,288,547 A1981
- Novel compounds of the gentamicin class3US 4,412,068 ASterling Drug Inc. · 1983